Trilogy Capital’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,701
Closed -$279K 338
2023
Q4
$279K Sell
10,701
-1,008
-9% -$22.5K 0.02% 217
2023
Q3
$260K Sell
11,709
-70,875
-86% -$1.88M 0.02% 220
2023
Q2
$2.52M Buy
82,584
+9,218
+13% +$300K 0.16% 102
2023
Q1
$2.54M Buy
73,366
+18,187
+33% +$645K 0.18% 79
2022
Q4
$2.06M Buy
55,179
+8,202
+17% +$308K 0.15% 96
2022
Q3
$1.48M Buy
46,977
+8,696
+23% +$322K 0.13% 80
2022
Q2
$1.45M Buy
38,281
+10,475
+38% +$450K 0.13% 77
2022
Q1
$1.25M Buy
+27,806
New +$1.37M 0.09% 96
2021
Q2
Sell
-3,877
Closed -$213K 190
2021
Q1
$213K Buy
+3,877
New +$192K 0.02% 152
2018
Q4
Sell
-30
Closed -$2K 568
2018
Q3
$2K Hold
30
﹤0.01% 521
2018
Q2
$2K Buy
+30
New +$1.93K ﹤0.01% 481

Other funds holding WBA

Trilogy Capital's WBA Position: Q1 2024 in Review

Trilogy Capital sold out of Walgreens Boots Alliance (WBA) in Q1 2024, closing a stake of 10,701 shares — an estimated $279K sold.

Trilogy Capital first reported a position in WBA in Q2 2018 and held it in 11 quarters. The position peaked at $2.54M in Q1 2023. 994 funds tracked by Wall St. Rank hold WBA as of Q1 2024.

  • Trilogy Capital reported no remaining Walgreens Boots Alliance position as of Q1 2024 after selling out during the quarter.
  • Trilogy Capital sold 10,701 Walgreens Boots Alliance shares in Q1 2024, an estimated $279K.
  • Trilogy Capital first reported a position in Walgreens Boots Alliance in Q2 2018 and held it in 11 quarters.
  • Trilogy Capital's Walgreens Boots Alliance position peaked at $2.54M in Q1 2023.
  • 994 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q1 2024.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.